logo
Select company
Select metric
$ 293.35MWorking Capital
VS
Market
71
Sector
76
Industry
80
History
50
$ 2.27Close
$ 1.66 - $ 12.28 52-Week Range
Ticker Information

Ticker

IOVA

Company Name

IOVANCE BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IOVANCE BIOTHERAPEUTICS INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IOVA - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 422.5M$ 129.16M$ 293.35M
3/31/2025$ 512.65M$ 122.69M$ 389.96M
12/31/2024$ 457.02M$ 122.34M$ 334.68M
9/30/2024$ 498.58M$ 118.06M$ 380.52M
6/30/2024$ 482.26M$ 93.64M$ 388.62M
3/31/2024$ 385.53M$ 83.21M$ 302.32M
12/31/2023$ 307.85M$ 110.31M$ 197.54M
9/30/2023$ 382.59M$ 90.95M$ 291.63M
6/30/2023$ 274.88M$ 88.64M$ 186.24M
3/31/2023$ 637.78M$ 87.27M$ 550.51M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IOVANCE BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Working Capital stands at $ 659.2M.
  • Over the past 5 years, IOVANCE BIOTHERAPEUTICS INC's average Working Capital has been $ 405.38M.
  • The median Working Capital for IOVANCE BIOTHERAPEUTICS INC during this period was $ 388.12M
  • IOVANCE BIOTHERAPEUTICS INC reached its highest Working Capital over the past 5 years at $ 659.2M.
  • The lowest Working Capital recorded by IOVANCE BIOTHERAPEUTICS INC in the same timeframe $ 186.24M

IOVANCE BIOTHERAPEUTICS INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
XERS : XERIS BIOPHARMA HOLDINGS INC $ 90.41MRCUS : ARCUS BIOSCIENCES INC $ 736MDNA : GINKGO BIOWORKS HOLDINGS INC $ 426.31MAKBA : AKEBIA THERAPEUTICS INC $ 115.94MAUPH : AURINIA PHARMACEUTICALS INC $ 330.7MMNKD : MANNKIND CORP $ 167.2MGERN : GERON CORP $ 441.31MSTOK : STOKE THERAPEUTICS INC $ 231.29MKROS : KEROS THERAPEUTICS INC $ 698.1MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ 443.21M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for IOVANCE BIOTHERAPEUTICS INC is calculated as follows: AssetsC [ $ 723.59M ] - LiabilitesC [ $ 64.39M ]
(=) Working Capital [ $ 659.2M ]

IOVA - Working Capital, Last 5 years

$ 186.24M

Minimum

Jun 30, 2023

$ 659.2M

Maximum

Sep 30, 2020

$ 405.38M

Average

$ 388.12M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.23M with a standard deviation of $ 173.96M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.79K
min$ -465.2M
max$ 607.04M
average$ 96.23M
median$ 32.11M
std$ 173.96M